Trials / Completed
CompletedNCT06647056
Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients With Psychogenic Nonepileptic Seizures
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Psychogenic non-epileptic seizures (PNES) are functional paroxysmal motor disorders that may be clinically suggestive of epilepsy but are not associated with the electroencephysiological and electroencephalographic changes of epilepsy. Thus, hyper-connectivity of the regions of the default mode network (DMN) linked to executive control could be involved in the impairment of cognitive control capacities in patients suffering from PNES. Also, the HYCORE study (NCT02329626), showed that dysregulation of frontal regions involved in attentional and emotional regulation is correlated with motor symptoms in patients with functional neurological disorders. The researchers of this study hypothesized that psilocybin would improve cognitive control in patients with PNES.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Psilocybin | Administration of psilocybin 25 mg |
| OTHER | MRI | Two standard MRI + fMRI scans before (D-3) and after (D5) treatment |
Timeline
- Start date
- 2024-12-19
- Primary completion
- 2025-01-03
- Completion
- 2025-05-22
- First posted
- 2024-10-17
- Last updated
- 2025-08-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06647056. Inclusion in this directory is not an endorsement.